Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: Elevated TNFRSF4 gene expression is a predictor of poor prognosis in non-M3 acute myeloid leukemia

Fig. 5

Survival analysis of patients with respect to TNFRSF4 expression. a Overall survival of 157 non-M3 AML patients with TNFRSF4 Z score ≥ 0 and TNFRSF4 Z score < 0. Survival analysis of patients with respect to TNFRSF4 expression based on patient risk stratification. b Overall survival of patients with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0) in patients with intermediate risk stratification. c Overall survival of patients with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0) in patients with poor risk stratification. Survival analysis of patients with respect to TNFRSF4 expression after stratification based on patient transplant status. d Overall survival and e disease-free survival of patients with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0) in patients who received a transplant. Survival analysis of patients with respect to TNFRSF4 expression based on age. f Overall survival of patients < 60 years of age with TNFRSF4 high (Z score ≥ 0) versus TNFRSF4 low (Z score < 0)

Back to article page